A phase 1, open-label, dose-escalating study to evaluate the safety, tolerability and immunogenicity of recombinant botulinum vaccine A/B in healthy adults
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Botulism vaccine (Primary)
- Indications Botulism
- Focus Adverse reactions
- 28 Sep 2008 Actual end date (Aug 2005) added as reported by CT.gov
- 28 Sep 2008 Status changed from recruiting to completed as reported by CT.gov
- 22 Oct 2005 New trial record.